Clinical Outcomes of Topical Ganciclovir Treatment in Cytomegalovirus Anterior Uveitis
NCT01486693 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2011-12-06
Summary
The purpose of this study was to evaluate long term efficacy and safety of topical ganciclovir treatment in Cytomegalovirus (CMV) anterior uveitis.
Conditions
- Anterior Uveitis
Sponsors & Collaborators
-
National Taiwan University Hospital
lead OTHER
Principal Investigators
-
I-Jong Wang, M.D PhD · National Taiwan University Hospital
Eligibility
- Min Age
- 40 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-10-31
- Primary Completion
- 2011-12-31
- Completion
- 2012-09-30
Countries
- Taiwan
Study Locations
More Related Trials
-
High-dose Intravitreal Injection of Ganciclovir for the Treatment of CMVR in HIV-negative Patients
NCT03598452 ·Status: COMPLETED ·Phase: NA
-
A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes
NCT00001062 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis
NCT00002134 ·Status: COMPLETED ·Phase: NA
-
A Study of Two Forms of Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS
NCT00002330 ·Status: COMPLETED ·Phase: NA
-
A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS
NCT00000688 ·Status: COMPLETED ·Phase: PHASE3
-
Ganciclovir Implant Study for Cytomegalovirus Retinitis
NCT00000118 ·Status: COMPLETED ·Phase: PHASE3
-
A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis
NCT00000698 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With Ganciclovir
NCT00000970 ·Status: COMPLETED ·Phase: PHASE1
-
An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous Access
NCT00002135 ·Status: COMPLETED ·Phase: NA
-
The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDS
NCT00000989 ·Status: COMPLETED ·Phase: NA
-
Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient
NCT00002025 ·Status: COMPLETED ·Phase: NA
-
A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS
NCT00002257 ·Status: COMPLETED ·Phase: NA
-
Phase III Randomized, Controlled Study of Ganciclovir for Symptomatic Congenital Cytomegalovirus Infection
NCT00004278 ·Status: COMPLETED ·Phase: PHASE3
-
Ganciclovir: Compassionate Use in Patients With Serious or Life-Threatening Cytomegalovirus Infections
NCT00002024 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDS
NCT00001999 ·Status: COMPLETED ·Phase: NA
-
An Open Label Evaluation of the Safety and Pharmacokinetics of Ganciclovir in Children
NCT00002015 ·Status: COMPLETED ·Phase: NA
-
A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS
NCT00002034 ·Status: COMPLETED ·Phase: NA
-
Ganciclovir 0,15% Ophthalmic Gel in the Treatment of Adenovirus Keratoconjuntivitis
NCT01349452 ·Status: COMPLETED ·Phase: NA
-
Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component
NCT00000665 ·Status: COMPLETED ·Phase: NA
-
Suppression of Cytomegalovirus Retinitis Utilizing High Dose Intravenous Acyclovir and Oral Zidovudine in Patients With AIDS
NCT00000693 ·Status: COMPLETED ·Phase: NA
-
A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Cannot Use Ganciclovir
NCT00000697 ·Status: WITHDRAWN ·Phase: PHASE2
-
Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by Adenovirus
NCT01600365 ·Status: UNKNOWN ·Phase: PHASE3
-
A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes
NCT00002377 ·Status: COMPLETED ·Phase: PHASE3
-
Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT)
NCT00000136 ·Status: COMPLETED ·Phase: PHASE3
-
Cytomegalovirus Reactivation in Cancer Patients Receiving Chemotherapy
NCT00366717 ·Status: COMPLETED